Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis
Authors
Keywords
-
Journal
PHYTOMEDICINE
Volume 102, Issue -, Pages 154166
Publisher
Elsevier BV
Online
2022-05-15
DOI
10.1016/j.phymed.2022.154166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between Use of Qingfei Paidu Tang and Mortality in Hospitalized Patients with COVID-19: A national retrospective registry study
- (2021) Lihua Zhang et al. PHYTOMEDICINE
- For Safer Use of Ivermectin in All Patients
- (2021) Masayo Komoda YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments’ Stringency Index from 148 countries
- (2021) Yan Ma et al. Infectious Diseases of Poverty
- Protection against COVID-19 injury by Qingfei Paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming
- (2020) Jian Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic
- (2020) Peng Cao et al. CARBOHYDRATE POLYMERS
- Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis
- (2020) Ming Liu et al. PHARMACOLOGICAL RESEARCH
- Hanshiyi Formula, an approved medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study
- (2020) Jiaxing Tian et al. PHARMACOLOGICAL RESEARCH
- Combating COVID-19 with integrated traditional Chinese and Western medicine in China
- (2020) Liqiang Ni et al. Acta Pharmaceutica Sinica B
- Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis
- (2020) Arthur Yin Fan et al. Journal of Integrative Medicine-JIM
- Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
- (2020) Siyi Xin et al. BIOMEDICINE & PHARMACOTHERAPY
- Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis
- (2020) Xingjiang Xiong et al. PHARMACOLOGICAL RESEARCH
- Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle
- (2020) Kanika Khanna et al. PHYTOMEDICINE
- Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection
- (2020) Timotius Ivan Hariyanto et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study
- (2020) Xin-yu Ji et al. PHYTOMEDICINE
- Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review
- (2020) Hui Luo et al. European Journal of Integrative Medicine
- Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
- (2017) Liu-Cheng Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started